1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global COVID-19 Medicine Market Size Growth Rate by Type (2021-2027) 1.2.2 Tablet 1.2.3 Injection 1.3 Market by Application 1.3.1 Global COVID-19 Medicine Market Share by Application (2021-2027) 1.3.2 Patients With Mild Symptoms 1.3.3 Critically Ill 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global COVID-19 Medicine Market Size 2.2 COVID-19 Medicine Market Size by Regions 2.2.1 COVID-19 Medicine Growth Rate by Regions (2021-2027) 2.2.2 COVID-19 Medicine Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 COVID-19 Medicine Revenue by Players (2020-2021) 3.2 COVID-19 Medicine Key Players Headquaters and Area Served 3.3 Key Players COVID-19 Medicine Product/Solution/Service 3.4 Date of Enter into COVID-19 Medicine Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global COVID-19 Medicine Market Size by Type (2021-2027) 4.2 Global COVID-19 Medicine Market Size by Application (2021-2027) 5 North America 5.1 North America COVID-19 Medicine Market Forecast (2021-2027) 5.2 COVID-19 Medicine Key Players in North America 5.3 North America COVID-19 Medicine Market Size by Type 5.4 North America COVID-19 Medicine Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe COVID-19 Medicine Market Forecast (2021-2027) 6.2 COVID-19 Medicine Key Players in Europe 6.3 Europe COVID-19 Medicine Market Size by Type 6.4 Europe COVID-19 Medicine Market Size by Application 7 Japan 7.1 Japan COVID-19 Medicine Market Forecast (2021-2027) 7.2 COVID-19 Medicine Key Players in Europe 7.3 Japan COVID-19 Medicine Market Size by Type 7.4 Japan COVID-19 Medicine Market Size by Application 8 Rest of World 8.1 China 8.1.1 China COVID-19 Medicine Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia COVID-19 Medicine Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India COVID-19 Medicine Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 Advanz Pharma 9.1.1 Advanz Pharma Company Details 9.1.2 Advanz Pharma Description and Business Overview 9.1.3 Advanz Pharma COVID-19 Medicine Introduction 9.1.4 Advanz Pharma Revenue in COVID-19 Medicine Business (2020-2021) 9.1.5 Advanz Pharma Recent Development 9.2 Kyung Poong 9.2.1 Kyung Poong Company Details 9.2.2 Kyung Poong Description and Business Overview 9.2.3 Kyung Poong COVID-19 Medicine Introduction 9.2.4 Kyung Poong Revenue in COVID-19 Medicine Business (2020-2021) 9.2.5 Kyung Poong Recent Development 9.3 Mylan 9.3.1 Mylan Company Details 9.3.2 Mylan Description and Business Overview 9.3.3 Mylan COVID-19 Medicine Introduction 9.3.4 Mylan Revenue in COVID-19 Medicine Business (2020-2021) 9.3.5 Mylan Recent Development 9.4 Novartis 9.4.1 Novartis Company Details 9.4.2 Novartis Description and Business Overview 9.4.3 Novartis COVID-19 Medicine Introduction 9.4.4 Novartis Revenue in COVID-19 Medicine Business (2020-2021) 9.4.5 Novartis Recent Development 9.5 Sanofi 9.5.1 Sanofi Company Details 9.5.2 Sanofi Description and Business Overview 9.5.3 Sanofi COVID-19 Medicine Introduction 9.5.4 Sanofi Revenue in COVID-19 Medicine Business (2020-2021) 9.5.5 Sanofi Recent Development 9.6 Apotex 9.6.1 Apotex Company Details 9.6.2 Apotex Description and Business Overview 9.6.3 Apotex COVID-19 Medicine Introduction 9.6.4 Apotex Revenue in COVID-19 Medicine Business (2020-2021) 9.6.5 Apotex Recent Development 9.7 Bayer 9.7.1 Bayer Company Details 9.7.2 Bayer Description and Business Overview 9.7.3 Bayer COVID-19 Medicine Introduction 9.7.4 Bayer Revenue in COVID-19 Medicine Business (2020-2021) 9.7.5 Bayer Recent Development 9.8 Guangzhou Baiyunshan Guanghua Pharmaceutical 9.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details 9.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview 9.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Introduction 9.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business (2020-2021) 9.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development 9.9 Ipca Laboratories 9.9.1 Ipca Laboratories Company Details 9.9.2 Ipca Laboratories Description and Business Overview 9.9.3 Ipca Laboratories COVID-19 Medicine Introduction 9.9.4 Ipca Laboratories Revenue in COVID-19 Medicine Business (2020-2021) 9.9.5 Ipca Laboratories Recent Development 9.10 Sichuan Sunny Hope 9.10.1 Sichuan Sunny Hope Company Details 9.10.2 Sichuan Sunny Hope Description and Business Overview 9.10.3 Sichuan Sunny Hope COVID-19 Medicine Introduction 9.10.4 Sichuan Sunny Hope Revenue in COVID-19 Medicine Business (2020-2021) 9.10.5 Sichuan Sunny Hope Recent Development 9.11 Zydus Cadila 9.11.1 Zydus Cadila Company Details 9.11.2 Zydus Cadila Description and Business Overview 9.11.3 Zydus Cadila COVID-19 Medicine Introduction 9.11.4 Zydus Cadila Revenue in COVID-19 Medicine Business (2020-2021) 9.11.5 Zydus Cadila Recent Development 9.12 Teva 9.12.1 Teva Company Details 9.12.2 Teva Description and Business Overview 9.12.3 Teva COVID-19 Medicine Introduction 9.12.4 Teva Revenue in COVID-19 Medicine Business (2020-2021) 9.12.5 Teva Recent Development 9.13 Sun Pharma 9.13.1 Sun Pharma Company Details 9.13.2 Sun Pharma Description and Business Overview 9.13.3 Sun Pharma COVID-19 Medicine Introduction 9.13.4 Sun Pharma Revenue in COVID-19 Medicine Business (2020-2021) 9.13.5 Sun Pharma Recent Development 9.14 Rising Pharmaceutical 9.14.1 Rising Pharmaceutical Company Details 9.14.2 Rising Pharmaceutical Description and Business Overview 9.14.3 Rising Pharmaceutical COVID-19 Medicine Introduction 9.14.4 Rising Pharmaceutical Revenue in COVID-19 Medicine Business (2020-2021) 9.14.5 Rising Pharmaceutical Recent Development 9.15 KPC Group 9.15.1 KPC Group Company Details 9.15.2 KPC Group Description and Business Overview 9.15.3 KPC Group COVID-19 Medicine Introduction 9.15.4 KPC Group Revenue in COVID-19 Medicine Business (2020-2021) 9.15.5 KPC Group Recent Development 9.16 Bristol Laboratories 9.16.1 Company Details 9.16.2 Bristol Laboratories Description and Business Overview 9.16.3 Bristol Laboratories COVID-19 Medicine Introduction 9.16.4 Bristol Laboratories Revenue in COVID-19 Medicine Business (2020-2021) 9.16.5 Bristol Laboratories Recent Development 9.17 Shanghai Zhongxisanwei 9.17.1 Shanghai Zhongxisanwei Company Details 9.17.2 Shanghai Zhongxisanwei Description and Business Overview 9.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Introduction 9.17.4 Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business (2020-2021) 9.17.5 Shanghai Zhongxisanwei Recent Development 9.18 Shanghai Pharma 9.18.1 Shanghai Pharma Company Details 9.18.2 Shanghai Pharma Description and Business Overview 9.18.3 Shanghai Pharma COVID-19 Medicine Introduction 9.18.4 Shanghai Pharma Revenue in COVID-19 Medicine Business (2020-2021) 9.18.5 Shanghai Pharma Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Global COVID-19 Medicine Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of Tablet Table 3. Key Players of Injection Table 4. Global COVID-19 Medicine Market Size Growth by Application (2021-2027) (US$ Million) Table 5. Global COVID-19 Medicine Market Size by Regions (2021-2027) (US$ Million) Table 6. Global COVID-19 Medicine Market Share by Regions (2021-2027) Table 7. Market Top Trends Table 8. Market Use Cases Table 9. Global COVID-19 Medicine Revenue by Players (2020-2021) (US$ Million) Table 10. Global COVID-19 Medicine Market Share by Players (2020-2021) Table 11. Key Players Headquarters and Area Served Table 12. Key Players COVID-19 Medicine Product Solution and Service Table 13. Date of Enter into COVID-19 Medicine Market Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Global COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million) Table 16. Global COVID-19 Medicine Market Size Share by Type (2021-2027) Table 17. Global COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million) Table 18. Global COVID-19 Medicine Market Size Share by Application (2021-2027) Table 19. North America Key Players COVID-19 Medicine Revenue (2020-2021) (US$ Million) Table 20. North America Key Players COVID-19 Medicine Market Share (2020-2021) Table 21. North America COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million) Table 22. North America COVID-19 Medicine Market Share by Type (2021-2027) Table 23. North America COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million) Table 24. North America COVID-19 Medicine Market Share by Application (2021-2027) Table 25. Europe Key Players COVID-19 Medicine Revenue (2020-2021) (US$ Million) Table 26. Europe Key Players COVID-19 Medicine Market Share (2020-2021) Table 27. Europe COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million) Table 28. Europe COVID-19 Medicine Market Share by Type (2021-2027) Table 29. Europe COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million) Table 30. Europe COVID-19 Medicine Market Share by Application (2021-2027) Table 31. Japan Key Players COVID-19 Medicine Revenue (2020-2021) (US$ Million) Table 32. Japan Key Players COVID-19 Medicine Market Share (2020-2021) Table 33. Japan COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million) Table 34. Japan COVID-19 Medicine Market Share by Type (2021-2027) Table 35. Japan COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million) Table 36. Japan COVID-19 Medicine Market Share by Application (2021-2027) Table 37. Key Players in China Table 38. Key Players in Southeast Asia Table 39. Key Players in India Table 40. Advanz Pharma Company Details Table 41. Advanz Pharma Description and Business Overview Table 42. Advanz Pharma COVID-19 Medicine Product Table 43. Advanz Pharma Revenue in COVID-19 Medicine Business 2020 and 2021 Table 44. Advanz Pharma Recent Development Table 45. Kyung Poong Company Details Table 46. Kyung Poong Description and Business Overview Table 47. Kyung Poong COVID-19 Medicine Product Table 48. Kyung Poong Revenue in COVID-19 Medicine Business 2020 and 2021 Table 49. Kyung Poong Recent Development Table 50. Mylan Company Details Table 51. Mylan Description and Business Overview Table 52. Mylan COVID-19 Medicine Product Table 53. Mylan Revenue in COVID-19 Medicine Business 2020 and 2021 Table 54. Mylan Recent Development Table 55. Novartis Company Details Table 56. Novartis Description and Business Overview Table 57. Novartis COVID-19 Medicine Product Table 58. Novartis Revenue in COVID-19 Medicine Business 2020 and 2021 Table 59. Novartis Recent Development Table 60. Sanofi Company Details Table 61. Sanofi Description and Business Overview Table 62. Sanofi COVID-19 Medicine Product Table 63. Sanofi Revenue in COVID-19 Medicine Business 2020 and 2021 Table 64. Sanofi Recent Development Table 65. Apotex Company Details Table 66. Apotex Description and Business Overview Table 67. Apotex COVID-19 Medicine Product Table 68. Apotex Revenue in COVID-19 Medicine Business 2020 and 2021 Table 69. Apotex Recent Development Table 70. Bayer Company Details Table 71. Bayer Description and Business Overview Table 72. Bayer COVID-19 Medicine Product Table 73. Bayer Revenue in COVID-19 Medicine Business 2020 and 2021 Table 74. Bayer Recent Development Table 75. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details Table 76. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview Table 77. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product Table 78. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business 2020 and 2021 Table 79. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 80. Ipca Laboratories Company Details Table 81. Ipca Laboratories Description and Business Overview Table 82. Ipca Laboratories COVID-19 Medicine Product Table 83. Ipca Laboratories Revenue in COVID-19 Medicine Business 2020 and 2021 Table 84. Ipca Laboratories Recent Development Table 85. Sichuan Sunny Hope Company Details Table 86. Sichuan Sunny Hope Description and Business Overview Table 87. Sichuan Sunny Hope COVID-19 Medicine Product Table 88. Sichuan Sunny Hope Revenue in COVID-19 Medicine Business 2020 and 2021 Table 89. Sichuan Sunny Hope Recent Development Table 90. Zydus Cadila Company Details Table 91. Zydus Cadila Description and Business Overview Table 92. Zydus Cadila COVID-19 Medicine Product Table 93. Zydus Cadila Revenue in COVID-19 Medicine Business 2020 and 2021 Table 94. Zydus Cadila Recent Development Table 95. Teva Company Details Table 96. Teva Description and Business Overview Table 97. Teva COVID-19 Medicine Product Table 98. Teva Revenue in COVID-19 Medicine Business 2020 and 2021 Table 99. Teva Recent Development Table 100. Sun Pharma Company Details Table 101. Sun Pharma Description and Business Overview Table 102. Sun Pharma COVID-19 Medicine Product Table 103. Sun Pharma Revenue in COVID-19 Medicine Business 2020 and 2021 Table 104. Sun Pharma Recent Development Table 105. Rising Pharmaceutical Company Details Table 106. Rising Pharmaceutical Description and Business Overview Table 107. Rising Pharmaceutical COVID-19 Medicine Product Table 108. Rising Pharmaceutical Revenue in COVID-19 Medicine Business 2020 and 2021 Table 109. Rising Pharmaceutical Recent Development Table 110. KPC Group Company Details Table 111. KPC Group Description and Business Overview Table 112. KPC Group COVID-19 Medicine Product Table 113. KPC Group Revenue in COVID-19 Medicine Business 2020 and 2021 Table 114. KPC Group Recent Development Table 115. Bristol Laboratories Company Details Table 116. Bristol Laboratories Description and Business Overview Table 117. Bristol Laboratories COVID-19 Medicine Product Table 118. Bristol Laboratories Revenue in COVID-19 Medicine Business 2020 and 2021 Table 119. Bristol Laboratories Recent Development Table 120. Shanghai Zhongxisanwei Company Details Table 121. Shanghai Zhongxisanwei Description and Business Overview Table 122. Shanghai Zhongxisanwei COVID-19 Medicine Product Table 123. Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business 2020 and 2021 Table 124. Shanghai Zhongxisanwei Recent Development Table 125. Shanghai Pharma Company Details Table 126. Shanghai Pharma Description and Business Overview Table 127. Shanghai Pharma COVID-19 Medicine Product Table 128. Shanghai Pharma Revenue in COVID-19 Medicine Business 2020 and 2021 Table 129. Shanghai Pharma Recent Development Table 130. COVID-19 Medicine Market Trends Table 131. COVID-19 Medicine Market Drivers Table 132. COVID-19 Medicine Market Challenges Table 133. COVID-19 Medicine Market Restraints Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Global COVID-19 Medicine Market Share by Type in 2021 & 2027 Figure 2. Tablet Features Figure 3. Injection Features Figure 4. Global COVID-19 Medicine Market Share by Application in 2021 & 2027 Figure 5. Patients With Mild Symptoms Case Studies Figure 6. Critically Ill Case Studies Figure 7. Other Case Studies Figure 8. COVID-19 Medicine Report Years Considered Figure 9. Global COVID-19 Medicine Market Size and Growth Rate (2020-2027) (US$ Million) Figure 10. Global COVID-19 Medicine Market Share by Regions (2020-2027) Figure 11. Global COVID-19 Medicine Market Share by Players in 2021 Figure 12. Global COVID-19 Medicine Market Size Market Share by Type (2021-2027) Figure 13. Global COVID-19 Medicine Market Size Market Share by Application (2021-2027) Figure 14. Global COVID-19 Medicine Revenue Market Share by Application in 2021 Figure 15. North America COVID-19 Medicine Market Size 2021-2027 (US$ Million) Figure 16. Europe COVID-19 Medicine Market Size 2021-2027 (US$ Million) Figure 17. Japan COVID-19 Medicine Market Size 2021-2027 (US$ Million) Figure 18. COVID-19 Medicine Market Size in China (2021-2027) (US$ Million) Figure 19. COVID-19 Medicine Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 20. COVID-19 Medicine Market Size in India (2021-2027) (US$ Million) Figure 21. Bottom-up and Top-down Approaches for This Report Figure 22. Data Triangulation Figure 23. Key Executives Interviewed

Advanz Pharma Kyung Poong Mylan Novartis Sanofi Apotex Bayer Guangzhou Baiyunshan Guanghua Pharmaceutical Ipca Laboratories Sichuan Sunny Hope Zydus Cadila Teva Sun Pharma Rising Pharmaceutical KPC Group Bristol Laboratories Shanghai Zhongxisanwei Shanghai Pharma